For CROs and revenue leaders in complex B2B sales — who are tired of arriving to shortlists that are already decided.
Your CRM, forecasts, and pipeline reviews are measuring the last 20% of a deal. The other 80% — where shortlists form and competitors get embedded — is invisible to your team.
of deal outcomes are decided at Awareness & Perception —
before a single commercial conversation begins
The difference between winning consistently and losing at the shortlist is not effort — it's timing. Revenue intelligence moves your team into the 80% of the decision that actually determines the outcome.
APAB™ maps the four real stages of an enterprise buying decision using behavioural signals — not rep-reported updates. Most GTM teams only show up at stage four.
Get your APAB™ gap analysis →The buyer recognises a problem. They don't know you exist yet. This is where the evaluation clock starts — and where most vendors are absent.
The buyer forms a view of your organisation vs. alternatives. Shortlists are built here — before any vendor is contacted. This is where most deals are won or lost.
An internal champion emerges. Stakeholder alignment and budget positioning are underway. You rarely know this conversation is happening.
RFP issued. Demo scheduled. 80% of the decision is already made. Most GTM teams only enter here — and wonder why win rates are low.
Revenue teams running RISE don't chase deals. They shape them — entering at the right stage, with the right intelligence, before competitors know the window exists.
A 4–6 week Diagnose engagement that quantifies your pipeline leakage, maps your APAB™ coverage gaps across target segments, and produces a board-ready ROI model built entirely on your own commercial data — not industry benchmarks. It stands alone and is designed to pay for itself.
No. RISE is a signal amplifier. Strategic decisions, relationship management, and enterprise credibility stay with your people. The system ensures your team is never late to a deal that's already been decided — and gives every rep the intelligence your best performers already generate intuitively.
No — RISE integrates with your existing CRM. The problem we solve is that CRMs measure rep-reported activity, not actual buyer behaviour. RISE adds a verified signal layer on top of your existing infrastructure and writes back to your CRM automatically.
The Diagnose phase (4–6 weeks) produces a board-ready ROI model. The Pilot phase (90 days) delivers measurable KPI data against a control group — pipeline velocity, conversion rates, and forecast accuracy — before any Scale investment is required.
Every phase has a clear go/no-go gate. You proceed only when the prior phase has demonstrated measurable value. The Diagnose phase stands alone — if the ROI model doesn't justify proceeding, you stop there with a clear diagnosis and recommended next steps.
RISE is built for B2B organisations with $20M–$500M in revenue, 50–500+ sales reps, multi-stakeholder buying cycles, and existing CRM infrastructure. It's not for early-stage teams without CRM infrastructure, transactional B2C businesses, or teams looking for generic AI tooling.
A 4–6 week pipeline audit built on your own commercial data. No benchmarks. No commitments beyond Phase 1.
What revenue leaders say
Working with complex B2B enterprises across energy, financial services, and industrial sectors.
We were arriving to RFPs where the shortlist was already set. RISE moved us upstream — now we're shaping decisions before our competitors know they exist.
The Diagnose phase alone was worth it. A board-ready ROI model built on our own data — not benchmarks. We knew exactly where pipeline was leaking within 4 weeks.
The AI Co-Conspirator encoded our top rep's approach across the whole team. That's our moat — it's something no competitor can replicate by buying a tool.